FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Threat Reduction Agency (DTRA) has awarded contract HDTRA126C0003 for Chemical / Biological Technologies research and development. This Cost Plus Fee contract was awarded via full and open competition under Broad Agency Announcement (BAA) HDTRA122S0002, Topic Call 5.
Scope of Work
This award supports applied research and development services related to national defense, specifically focusing on chemical and biological technologies. The work falls under the scope of the FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement.
Contract & Timeline
- Type: Cost Plus Fee
- Contract Number: HDTRA126C0003
- Awarded Under: Broad Agency Announcement (BAA) HDTRA122S0002, Topic Call 5
- Set-Aside: None specified
- Award Date: June 3, 2026
- Place of Performance: Annapolis, MD
Evaluation
This contract was awarded following a full and open competition process.
Additional Notes
This award notice pertains to the DTRA's ongoing efforts in defense-related applied research.